
CosmicTaco
CCI Approves 360 ONE, Ranjan Pai's PharmEasy Stake
- The Competition Commission of India (CCI) approved 360 ONE and Claypond Capital's proposal to acquire additional stakes in PharmEasy.
- This follows a $216 million funding round last year, where Ranjan Pai acquired an estimated 12% stake in the company.
- PharmEasy is currently facing financial challenges, including a funding crunch and valuation markdowns.
- The company is also dealing with uncertainties regarding its future IPO plans.
- Details about the size and amount of the new deal remain unclear.
Source: Inc42
2mo ago
Talking product sense with Ridhi
9 min AI interview5 questions

You're early. There are no comments yet.
Be the first to comment.
Discover more
Curated from across